Elsa comes to Evidera’s Market Access Consulting team from a lengthy career in the biopharmaceutical industry. She has focused on the global market access discipline for the past decade, most recently at AbbVie, as well as Amgen. She has led the development of the access and reimbursement strategy for pipeline assets across oncology, neuroscience, inflammation, diabetes, cardiovascular, and renal therapeutic areas. Prior to her global experience, she held various positions in U.S. market access as well as product management. Elsa graduated from Princeton University with a specialization in public policy. After graduation, she worked as a policy analyst, grant writer, and program administrator for New York City.